UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032821
Receipt number R000037432
Scientific Title Effect of inner limiting membrane peeling on retinal thickness and retinal vascular layer for epiretinal membrane and macular hole
Date of disclosure of the study information 2018/06/01
Last modified on 2021/12/02 09:08:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of inner limiting membrane peeling on retinal thickness and retinal vascular layer for epiretinal membrane and macular hole

Acronym

Effect of ILP peeling on retinal thickness for ERM and MH

Scientific Title

Effect of inner limiting membrane peeling on retinal thickness and retinal vascular layer for epiretinal membrane and macular hole

Scientific Title:Acronym

Effect of ILP peeling on retinal thickness for ERM and MH

Region

Japan


Condition

Condition

epiretinal membrane and macular hole

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effectiveness and safety of internal limiting membrane peeling in the treatment for epiretinal membrane and macular hole.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

retinal thinning

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients who have vitrectomy surgeries ERM and MH and who agree with this study.

Key exclusion criteria

n/a

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hiroki
Middle name
Last name Kaneko

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Ophthalmology

Zip code

466-8550

Address

65 Tsurumai-cho, Showa-ku, Nagoya

TEL

+81-52-7442277

Email

h-kaneko@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Hiroki
Middle name
Last name Kaneko

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Ophthalmology

Zip code

466-8550

Address

65 Tsurumai-cho, Showa-ku, Nagoya

TEL

+81-52-7442277

Homepage URL


Email

h-kaneko@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University

Institute

Department

Personal name



Funding Source

Organization

n/a

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya University Graduate School of Medicine

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Japan

Tel

+81-52-7442277

Email

hiroki.kaneko2@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 07 Month 20 Day

Date of IRB

2017 Year 07 Month 20 Day

Anticipated trial start date

2017 Year 07 Month 20 Day

Last follow-up date

2021 Year 12 Month 01 Day

Date of closure to data entry

2021 Year 12 Month 01 Day

Date trial data considered complete

2021 Year 12 Month 01 Day

Date analysis concluded

2021 Year 12 Month 01 Day


Other

Other related information

limited patients recruitment in the approved facility


Management information

Registered date

2018 Year 05 Month 31 Day

Last modified on

2021 Year 12 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037432


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name